JAMA Network Home
Sign In
Ophthalmic Images

Hemorrhagic Occlusive Retinal Vasculitis and Intravitreal Anti-VEGF

JAMA Ophthalmology 10.1001/jamaophthalmol.2026.0538

April 02, 2026 at 11:00 AM EDT

Read the full article

This case report discusses bilateral vision loss 2 weeks after second bilateral intravitreal injection of the anti–vascular endothelial growth factor (VEGF) brolucizumab for diabetic macular edema in a woman in her 60s.

Corresponding Author: Prithvi Ramtohul, MD, Centre Hospitalier Universitaire de l’Hôpital Nord, Chemin des Bourrely, 13015 Marseille, France (pramtohul@me.com).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2026.0538?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040226

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks